- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 22, 2025 | 40.65M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $32.71M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $23.07M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $686.57M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $667.3M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $164.93M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $159.43M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $707.18M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $656.88M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $464.91M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $426.64M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.39B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.32B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 41.32M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $13.32M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $1.66M |
| Capex | Q1 2025 · Mar 31, 2024 | $13.25M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.69M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.12 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.13 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $40.33M |
| Net Income | Q1 2025 · Mar 31, 2024 | $5.14M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $12.44M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $52.71M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $174.39M |
| Revenue | Q1 2025 · Mar 31, 2024 | $227.1M |